G. Mohr

发表

'Shed' furin: mapping of the cleavage determinants and identification of its C-terminus.

F. Dorner, M. Himmelspach, B. Plaimauer, 2001, The Biochemical journal.

Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura.

F. Dorner, P. Knöbl, M. Dockal, 2003, Blood.

Strategies for recombinant Furin employment in a biotechnological process: complete target protein precursor cleavage

F. Dorner, H. Schwarz, P. Turecek, 1999, Cytotechnology.

Production of highly homogeneous and structurally intact recombinant von Willebrand factor multimers by furin‐mediated propeptide removal in vitro

F. Dorner, O. Kistner, M. Himmelspach, 1996, Biotechnology and applied biochemistry.

High Yield Expression of Recombinant Plasma Factors: Use of Recombinant Endoprotease Derivatives In Vivo and In Vitro

F. Dorner, B. Fischer, M. Himmelspach, 1998 .

thrombocytopenic purpura (TTP) factor-cleaving protease (ADAMTS-13) in a patient with thrombotic Non-neutralizing IgM and IgG antibodies to von Willebrand

F. Scheiflinger, B. Plaimauer, G. Mohr, 2013 .

Modulation of ADAMTS13 secretion and specific activity by a combination of common amino acid polymorphisms and a missense mutation.

S. Ferrari, J. Fuhrmann, F. Scheiflinger, 2006, Blood.

Permanent mycoplasma removal from tissue culture cells: A genetic approach

F. Dorner, M. Himmelspach, B. Plaimauer, 2000 .

Selective functional activity measurement of a PEGylated protein with a modification‐dependent activity assay

H. Schwarz, A. Weber, A. Engelmaier, 2017, Journal of pharmaceutical and biomedical analysis.

mutation combination of common amino acid polymorphisms and a missense Modulation of ADAMTS13 secretion and specific activity by a

J. Fuhrmann, F. Scheiflinger, B. Plaimauer, 2013 .